These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 30414516)

  • 1. Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects.
    Bonnet J; Garcia C; Leger T; Couquet MP; Vignoles P; Vatunga G; Ndung'u J; Boudot C; Bisser S; Courtioux B
    J Proteomics; 2019 Mar; 196():150-161. PubMed ID: 30414516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of cerebrospinal fluid from the meningo-encephalitic stage of T. b. gambiense and rhodesiense sleeping sickness patients using TMT quantitative proteomics.
    Tiberti N; Sanchez JC
    Data Brief; 2015 Sep; 4():400-5. PubMed ID: 26306311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasis.
    Tiberti N; Hainard A; Lejon V; Robin X; Ngoyi DM; Turck N; Matovu E; Enyaru J; Ndung'u JM; Scherl A; Dayon L; Sanchez JC
    Mol Cell Proteomics; 2010 Dec; 9(12):2783-95. PubMed ID: 20724469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal Fluid-Derived Microvesicles From Sleeping Sickness Patients Alter Protein Expression in Human Astrocytes.
    Dozio V; Lejon V; Mumba Ngoyi D; Büscher P; Sanchez JC; Tiberti N
    Front Cell Infect Microbiol; 2019; 9():391. PubMed ID: 31824868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human African trypanosomiasis].
    Dumas M; Bouteille B
    C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of human African trypanosomiasis.
    Burchmore RJ; Ogbunude PO; Enanga B; Barrett MP
    Curr Pharm Des; 2002; 8(4):256-67. PubMed ID: 11860365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis.
    Kennedy PGE; Rodgers J
    Front Immunol; 2019; 10():39. PubMed ID: 30740102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients.
    Hainard A; Tiberti N; Robin X; Lejon V; Ngoyi DM; Matovu E; Enyaru JC; Fouda C; Ndung'u JM; Lisacek F; Müller M; Turck N; Sanchez JC
    PLoS Negl Trop Dis; 2009 Jun; 3(6):e459. PubMed ID: 19554086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priorities for the elimination of sleeping sickness.
    Welburn SC; Maudlin I
    Adv Parasitol; 2012; 79():299-337. PubMed ID: 22726645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human African trypanosomiasis in non-endemic countries.
    Sudarshi D; Brown M
    Clin Med (Lond); 2015 Feb; 15(1):70-3. PubMed ID: 25650203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
    Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of antihuman African trypanosomiasis drugs across the blood-brain and blood-CSF barriers.
    Sekhar GN; Watson CP; Fidanboylu M; Sanderson L; Thomas SA
    Adv Pharmacol; 2014; 71():245-75. PubMed ID: 25307219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study.
    Kande Betu Ku Mesu V; Mutombo Kalonji W; Bardonneau C; Valverde Mordt O; Ngolo Tete D; Blesson S; Simon F; Delhomme S; Bernhard S; Mahenzi Mbembo H; Mpia Moke C; Lumeya Vuvu S; Mudji E'kitiak J; Akwaso Masa F; Mukendi Ilunga M; Mpoyi Muamba Nzambi D; Mayala Malu T; Kapongo Tshilumbwa S; Botalema Bolengi F; Nkieri Matsho M; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
    Lancet Glob Health; 2021 Jul; 9(7):e999-e1008. PubMed ID: 34143998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response.
    MacLean L; Reiber H; Kennedy PG; Sternberg JM
    PLoS Negl Trop Dis; 2012; 6(10):e1857. PubMed ID: 23145191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda.
    Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC
    Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The separation of trypanosomes from blood by anion exchange chromatography: From Sheila Lanham's discovery 50 years ago to a gold standard for sleeping sickness diagnosis.
    Lejon V; Büscher P; Nzoumbou-Boko R; Bossard G; Jamonneau V; Bucheton B; Truc P; Lemesre JL; Solano P; Vincendeau P
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007051. PubMed ID: 30817751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human African trypanosomiasis in endemic populations and travellers.
    Blum JA; Neumayr AL; Hatz CF
    Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):905-13. PubMed ID: 21901632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing passive surveillance for T. b. rhodesiense human african trypanosomiasis in Uganda.
    Acup C; Bardosh KL; Picozzi K; Waiswa C; Welburn SC
    Acta Trop; 2017 Jan; 165():230-239. PubMed ID: 27212706
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.